Herpes Simplex Encephalitis (HSE)
What is Herpes Simplex Encephalitis (HSE)?
Herpes simplex encephalitis is a rare but serious brain infection caused by the herpes simplex virus. The condition happens when HSV-1, the same virus that causes cold sores, spreads to the brain and causes inflammation. This is the most common type of viral encephalitis in the United States.
HSV-1 causes about 90% of herpes simplex encephalitis cases. The virus typically affects the temporal lobes of the brain, which control memory, emotion, and language. Without quick treatment, HSE can cause permanent brain damage or death. Early diagnosis and antiviral treatment can save lives and reduce long-term complications.
Most people with HSV-1 antibodies never develop encephalitis. The infection is rare, affecting about 1 in 250,000 to 500,000 people each year. Anyone can develop HSE, from newborns to older adults. The condition requires immediate medical attention and hospitalization.
Symptoms
- Sudden high fever, often above 101°F
- Severe headache that doesn't respond to pain relievers
- Confusion, disorientation, or personality changes
- Seizures or convulsions
- Difficulty speaking or understanding language
- Memory problems or inability to recognize familiar people
- Hallucinations or unusual behavior
- Weakness or paralysis on one side of the body
- Loss of consciousness or coma
- Sensitivity to light
Symptoms usually develop over several days but can appear suddenly. Some people may have flu-like symptoms before neurological symptoms begin. Early recognition is critical because brain damage can occur quickly without treatment.
Concerned about Herpes Simplex Encephalitis (HSE)? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Herpes simplex encephalitis occurs when HSV-1 enters the brain and causes inflammation. The virus can reach the brain through two main pathways. In some cases, it spreads from an active cold sore infection through nerve pathways directly into the brain. In other cases, the virus reactivates from a dormant state in the nervous system and travels to the brain. Scientists don't fully understand why some people develop this severe complication while most people with HSV-1 never experience brain infection.
Risk factors include having a weakened immune system from conditions like HIV or cancer treatment. Newborns can develop HSE if they contract HSV during birth. Certain genetic factors may make some people more susceptible to severe HSV infections. Stress, illness, or other triggers that reactivate dormant herpes virus may play a role. Most people who develop HSE have no clear risk factors or warning signs beforehand.
How it's diagnosed
Doctors diagnose herpes simplex encephalitis using brain imaging, spinal fluid analysis, and blood tests. An MRI or CT scan can show inflammation in the temporal lobes. A lumbar puncture collects cerebrospinal fluid to test for HSV DNA using PCR testing. Blood tests measure HSV-1 antibodies to confirm prior exposure to the virus. Rite Aid offers HSV-1 IgG antibody testing as an add-on to help assess your herpes simplex virus status.
Early diagnosis is critical because treatment must start immediately. Doctors often begin antiviral medication before test results come back if HSE is suspected. EEG brain wave testing may show abnormal electrical activity in affected brain areas. The combination of clinical symptoms, imaging findings, and laboratory tests confirms the diagnosis. Quick action can mean the difference between recovery and severe disability.
Treatment options
- Immediate hospitalization in an intensive care unit
- Intravenous acyclovir antiviral medication for 14 to 21 days
- Anti-seizure medications if seizures occur
- Medications to reduce brain swelling and pressure
- Supportive care including fluids and fever management
- Physical therapy and rehabilitation after acute treatment
- Speech therapy for language and communication problems
- Occupational therapy to regain daily living skills
- Neuropsychological support for memory and cognitive issues
- Long-term follow-up care with neurologists
Need testing for Herpes Simplex Encephalitis (HSE)? Add it to your panel.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Regular herpes simplex virus typically causes cold sores on the lips or genital sores. Herpes simplex encephalitis is a rare complication where the virus infects the brain tissue instead. Most people with HSV-1 will never develop encephalitis. The brain infection is a medical emergency requiring immediate hospitalization and antiviral treatment.
Symptoms usually develop over several days, though they can appear more suddenly in some cases. Early symptoms may include fever, headache, and confusion. Neurological symptoms like seizures, speech problems, and altered consciousness typically follow within days. Because brain damage occurs rapidly, seeking immediate medical care at the first sign of neurological symptoms is critical.
Antiviral treatment with intravenous acyclovir can stop the active infection and save lives. However, some people experience lasting effects from brain damage that occurred before treatment began. Early treatment within the first few days gives the best chance of full recovery. Many survivors need ongoing rehabilitation and therapy for memory, speech, or movement problems.
HSE can affect anyone at any age, from newborns to older adults. People with weakened immune systems have higher risk. Newborns can contract the virus during birth from mothers with active genital herpes. However, most people who develop HSE have no identifiable risk factors and have healthy immune systems.
HSV-1 IgG antibody tests show if you have been exposed to the herpes simplex virus type 1. This blood test helps confirm prior infection but cannot diagnose active encephalitis alone. Doctors combine blood test results with spinal fluid analysis and brain imaging to diagnose HSE. Rite Aid offers HSV-1 IgG testing as an add-on to assess your viral antibody status.
The brain infection itself is not contagious from person to person. However, the herpes simplex virus can spread through direct contact with cold sores or saliva. Most people contract HSV-1 during childhood through casual contact like sharing utensils or kissing. Having the virus does not mean you will develop encephalitis, which is extremely rare.
Without treatment, HSE is fatal in about 70% of cases. With prompt antiviral treatment, survival rates improve to 70% to 80%. However, many survivors have lasting neurological problems including memory loss, personality changes, or seizures. Starting treatment within the first 48 hours of symptom onset gives the best outcomes.
Recurrent herpes simplex encephalitis is rare but possible. Some people experience a second episode months or years after the first infection. Doctors may recommend longer courses of antiviral medication or preventive treatment for people at high risk of recurrence. Most people who recover from HSE do not experience another episode.
Common long-term effects include memory problems, difficulty with language and communication, and personality changes. Some survivors experience ongoing seizures requiring medication. Physical effects can include weakness on one side of the body or coordination problems. The severity of lasting effects depends on how quickly treatment began and which brain areas were damaged.
There is no way to completely prevent HSE since most cases occur unpredictably in people with existing HSV-1 infection. Avoiding initial HSV-1 infection through good hygiene and avoiding contact with active cold sores helps. Pregnant women with active genital herpes may receive antiviral medication to protect newborns during delivery. Seeking immediate medical care for severe headache, fever, and confusion allows for early treatment.